Completed PHASE2 INTERVENTIONAL 2-arm NCT00468247

Registration Enabling Study of the Safety and Efficacy of the Use of the Navigator Circulatory Management System (NAV-1)

A Prospective,Open,Multicentre,RCT to Assess the Safety & Efficacy of Navigator v Conventional Care in Post-op Cardiac Surgery Patients Undergoing CABG &/or Heart Valve Repair/Replacement Utilising Heart Lung Perfusion Pump(The NAV-1 Study)

Sponsor: Applied Physiology Pty Ltd

Conditions Critical Illness Intensive Care

Interventions Conventional care Navigator

Updated 5 times since 2017 Last updated: Apr 24, 2008 Started: Mar 31, 2007 Primary completion: Apr 30, 2008 Completion: Apr 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Critical Illness and Intensive Care, this trial is completed. The trial is conducted by Applied Physiology Pty Ltd and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Applied Physiology Pty Ltd
Trident Clinical Research Pty Ltd

Data source: Applied Physiology Pty Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia
• Sydney, Australia